ASH 2022 | Improving the identification of patients with high-risk multiple myeloma
Mehmet Samur
• 10 Dec 2022
Mehmet Samur, PhD, Dana-Farber Cancer Institute, Boston, MA, describes the advantages of new technologies and of datasets collected from large cohorts to identify patients with high-risk multiple myeloma more efficiently. This interview took place at the 64th ASH Annual Meeting and Exposition congress held in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
